Fat loss drug top pharma seller, Augmentin no 2
NEW DELHI: Weight-loss therapy drug Eli Lilly’s Mounjaro has become the top selling brand in the domestic pharma retail market with sales of nearly Rs 100 crore in Oct, indicating the huge popularity of such treatments across India. Mounjaro has overtaken GSK’s widely prescribed antibiotic and long-established market leader, Augmentin, which totalled sales of Rs…